Publications

• Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia.
  Breast Cancer Res Treat Volume: 205 Page(s): 609 - 618
  06/01/2024 Authors: Collin LJ; Jones J; Nash R; Switchenko JM; Ward KC; McCullough LE
• Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity.
  Cancer Volume: 129 Page(s): 2192 - 2200
  07/15/2023 Authors: Gordon MJ; Jones JE; George B; Peterson C; Burger JA; Jain N; Keating M; Wierda WG; Durand J-B; Ferrajoli A
• When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management.
  Am Soc Clin Oncol Educ Book Volume: 41 Page(s): 1 - 11
  03/01/2021 Authors: Obeng-Gyasi S; Coles CE; Jones J; Sacks R; Lightowlers S; Bliss JM; Brunt AM; Haviland JS; Kirby AM; Kalinsky K
• Assessing the long-term effects of treatment with ibrutinib on blood pressure in patients with chronic lymphocytic leukemia
  Volume: 61 Page(s): 89 - 90
  03/16/2020 Authors: Jones J; Peterson C; Burger JA; Jain N; Keating M; Durand J-B; Ferrajoli A
• Long-term effects of ibrutinib on blood pressure in patients with chronic lymphocytic leukemia (CLL).
  Volume: 37
  05/20/2019 Authors: Jones J; George B; Peterson CB; Burger JA; Jain N; Wierda WG; Keating MJ; Durand J-B; Ferrajoli A
• Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy.
  Leuk Lymphoma Volume: 60 Page(s): 519 - 522
  02/01/2019 Authors: Taneja A; Jones J; Pittaluga S; Maric I; Farooqui M; Ahn IE; Wiestner A; Sun C